Premier Scientific Conference on Diagnosis, Evaluation, Treatment & Management of Heart Valve Diseases Scheduled for April in New York City

Share Article

The Fourth Annual Joint Scientific Session of the Heart Valve Society of America (HVSA) & Society for Heart Valve Disease (SHVD) — Valves in the Heart of the Big Apple: Evaluation & Management of Valvular Heart Diseases 2012 — will take place from April 12 – 14, 2012 at the New York Marriott Marquis in New York City.

News Image
The conference will be two and –one-half days of state-of-the-art lectures, Meet the Experts programs, teaching sessions including hands-on classes in 3D Echo cropping and Robot Manipulation, and case presentations.

The Fourth Annual Joint Scientific Session of the Heart Valve Society of America (HVSA) & Society for Heart Valve Disease (SHVD) — Valves in the Heart of the Big Apple: Evaluation & Management of Valvular Heart Diseases 2012 — will take place from April 12 – 14, 2012 at the New York Marriott Marquis in New York City.

The conference — which focuses on diagnosis, evaluation, intervention and treatment of heart valve diseases — will be two and –one-half days of state-of-the-art lectures, Meet the Experts programs, teaching sessions including hands-on classes in 3D Echo cropping and Robot Manipulation, and case presentations. The faculty is made up of over 130 of the world’s top specialists in the field. There will also be oral presentations of referred abstracts and cases.

Valvular heart diseases are among the most prominent causes of heart failure and premature cardiac death. It is estimated that more than 15 million Americans have some type of heart valve abnormality, and in more than five million, the disease is moderate to severe. Three to four million will require surgery at some time in their lives.

Valve diseases increase in frequency as people grow older. With the aging of the Baby Boom generation, heart valve diseases are emerging as an important public health concern.

Valves in the Heart of the Big Apple VII: Evaluation and Management of Valvular Heart Diseases 2012 will provide state-of-the-art information for cardiologists, cardiothoracic surgeons, interventionalists, other physicians, researchers, allied health professionals, fellows and students.

Course directors are:

Maurice E. Sarano, MD, Mayo Clinic, Rochester, MN
Hartzell Schaff, MD, Mayo Clinic, Rochester, MN
Jeffrey S. Borer, MD, SUNY Downstate Medical Center, Brooklyn, NY, HVSA President
José-Luis Pomar, MD, Hospital Clinico de Barcelona, Barcelona, Spain, SHVD President

The conference is co-sponsored by SUNY Downstate Medical Center and the New York Cardiological Society of the New York State Chapter/American College of Cardiology.

The scientific session has been approved for AMA PRA Category 1 Credit CME credits, which being provided by SUNY Downstate Medical Center, Office of Continuing Medical Education.

Educational grants for the conference have been provided by: Platinum — Edwards Lifesciences and St. Jude Medical; Silver — Abbott Vascular, Medtronic and Sorin Group. Other supporters include Intuitive Surgical and Philips Healthcare.

The Heart Valve Society of America was founded to advance recognition and knowledge of the field by promoting research, educating medical professionals about the evaluation and treatment of heart valve disease, serving as an informational resource, and encouraging and facilitating education of future heart valve disease specialists.
The Society for Heart Valve Disease has as its objective to undertake, promote, support and encourage research and educate the public in the causes, prevention and treatment of heart valve disease.

Visit the conference website to view the program, faculty and to register.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Leslie J. Yerman
COMMUNICATIONS CONSULTANT
(212) 327-2107
Email >
Visit website